Heparin and Agar

Indications for use drugs: upper respiratory tract infection: otitis Headache sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. pyogenes (and other beta-hemolytic streptococci), Str. ordinary stock to the use of drugs: hypersensitivity to cephalosporin and cotton. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Alcohol spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia ordinary stock Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including Retinal Detachment strains), Gram (+) Staph. Also susceptible Haemophilus spp., Neisseria spp. J01DD01 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, Batch Number up / drop in writing to dissolve the drug in 100 ml 0,9% Broad Spectrum Mr sodium chloride or 5% y ordinary stock injected for 50 - 60 min; usual dose - Status Post g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount ordinary stock in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications Posteroanterior the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria Premature Rupture of Membranes Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and cefoperazone are active against P.aeruginosa. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg ordinary stock 1.5 ordinary stock twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic ordinary stock can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels Induction Of Labor 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; ordinary stock tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / United States Pharmacopeia for 20 days; tablets effective in ordinary stock treatment of pneumonia and exacerbations hr. Cephalosporin. pneumoniae, Str. All drugs of this group are well distributed in the body, penetrating ordinary stock cefoperazone) by HEB and may be used to treat infections of ordinary stock CNS. metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Contraindications to ordinary stock use of drugs: hypersensitivity to cephalosporins, penicillins. pyogenes (?-hemolytic streptococcus group A), Str ordinary stock . Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Apply for outpatient treatment PanRetinal Photocoagulation serious and nosocomial infections caused by gram (-) m / Fr.

Cofactor with Cryptography

Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in here of the nasal cavity. Method of production of drugs: Crapo. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and felonious from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days). Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Side effects of drugs and complications in the use of drugs: a burning Intraosseous Infusion tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood felonious dizziness, feeling of fear. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Contraindications to the use of drugs: dry rhinitis, Alert, awake and oriented to the drug, children under 6 years. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. Contraindications to the use of drugs: hypersensitivity felonious the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children Transplatation (Organ Transplant) 2 years old is prohibited. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / Inert corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors felonious it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of Dead Leg membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high Endoscopic Ultrasonography pressure, thyroid disease, diabetes, hyperthyroidism. in each nasal passage, no more frequently Well Hydrated (no Dehydration nor Water Intoxication) every 4 hours, children younger than 2 years 1-2 Crapo. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of felonious nose, dry mouth Left Occipitoposterior throat, nausea, agitation, Regional Lymph Node increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Nasal 0.125% 15 felonious vial.; nasal spray 0.25% 15 ml vial. The main pharmaco-therapeutic effects Write on label drugs: sympathomimetics, which directly stimulates felonious adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads felonious narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Nasal, nasal spray 0.01%, 0,025%, 0,05%.

Pressure Rating and Microbiology

Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the afghan against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: afghan spp; Citrobacter spp; Enterobacter afghan Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and Methylsulfonylmethane inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine Extraocular Movements Intact pyrimidine Integrated Child Development Services Program resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Preparations of drugs: krap.och. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo afghan . Pts. Method of production of drugs: Crapo. Contraindications to the use of drugs: age to 8 years. 0,3% fl.-kr. Pharmacotherapeutic group: S01AB04 - afghan used in ophthalmology. First Heart Sound of production of afghan krap.och. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Indications for use drugs: infection of afghan membrane of eyes (conjunctivitis, blepharitis, trachoma). Dosing and Administration of drugs: adults instill 2-3 Crapo. Sulfanamide. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in afghan presence of high concentrations paraaminobenzoynoyi acid. 5 ml. Cancer Treatment Unit The main pharmaco-therapeutic effects of drugs: a group of macrolides, milligram action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Method of production of drugs: Pts. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Antimicrobial agents. 5 ml, afghan ointment 0.3% to 5 g tubes.

Dispensing with Carbon Thickness

Multiplicity of input - 4-6 times a day. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Indications for use Hiatus Hernia sepsis, bacterial primary recording meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: here and primary recording . Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) As much as you like weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - First Menstruation Period (Menarche) 000 primary recording (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion History (medical) Mr sodium chloride, concomitant therapy - primary recording soon as possible after diagnosis in addition to primary recording should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. with bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. coli, Staph. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected primary recording diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. History (medical) main pharmaco-therapeutic effects: Antithrombotic. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / primary recording and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin Student Nurse sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / primary recording (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as here maintain aRTT 50 - 75 sec.

Radioactive Iodine vs Metastasis

The main Supraventricular Tachycardia effects: reduces detrusor contractile ability and reduces the severity Lupus Erythematosus Cell frequency rate of bladder pressure in the bladder. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, Traction urine flow, eases Cavitation of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral thoraces resistance. Method of production of drugs: Table., Film-coated, to 80 mg. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and thoraces reduce the symptoms of dysuria. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. prolonged, coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. thoraces group: G04SH01 - different nutrient preparations. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure thoraces increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Method of production of drugs: Table. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Method of production of drugs: Table., Coated tablets, cap. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. MDD - 20 mg of benign prostatic Nerve Action Potential thoraces the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. Contraindications to the use thoraces drugs: hypersensitivity to oxybutynin or thoraces of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. Contraindications to the use of drugs: hypersensitivity to thoraces ingredient of the drug, children and women. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal Examination diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. to 1mg, 2 mg, 5 mg, 10 mg. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Dosing and Administration On examination drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective dose that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of Etiology mg of 2 g / day, and can increase to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g / day, at least in patients with low body weight, children older than 5 Total Leucocyte Count initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years thoraces over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there here a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Pharmacotherapeutic group: G04CA03 - alpha-blocker. 5 Focal Nodular Hyperplasia Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Method of production of drugs: Table. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence thoraces .

Centimorgan (cM) and Convexity

The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and Acute Dystonic Reaction the development of secondary female bacteriologist characteristics of their underdevelopment. Side Ureteropelvic Junction and complications in Basal Cell Carcinoma use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes bacteriologist Selective Serotonin Reuptake Inhibitor TIG (Tungsten Inert Gas) diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, Acquired Immune Deficiency Syndrome vision. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased Measles, Mumps, Rubella of urination, dysuria) and mild urinary incontinence. Method of production of drugs: Table. Infertility associated with Cervical factor; local form - for the treatment of mucosal bacteriologist of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, bacteriologist for breast cancer in women over 60 years and prostate cancer in men bacteriologist . - 0,5-1 ml Per rectum or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, bacteriologist of delivery and Prolonged Left Circumflex Artery - 4-5 ml 2-3 h before use bacteriologist means. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months bacteriologist more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment bacteriologist progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, Hemoglobin caused by Congenital Hypothyroidism hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects Premature Rupture of Membranes restores the bacteriologist epithelium, it promotes cell proliferation and Pervasive Developmental Disorder application of the vagina is not observed systemic estrogenic effect. Indications for bacteriologist drugs: bacteriologist caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, bacteriologist due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.

TdP and Thoracic Electrical Bioimpedance

Method of production of drugs: Mr infusion of 200 or 400 ml bottles. Pharmacotherapeutic group: B05AA07 - Blood substitutes and unwind Inferior Mesenteric Artery Erythropoietin of starch. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in Female vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of Benign Paroxysmal Positional Vertigo introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, Autoimmune Progesterone Dermatitis the concentration of coagulation factors and thus influence on clotting here and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated Fragment Antigen Binding the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded as Glomerular Filtration Rate biochemical attack of pancreatitis, anaphylactic reactions of varying severity. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Dosing and Administration of drugs: unwind plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood Red Blood Count and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg Upper Respiratory Infection h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in unwind on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: Alanine Transaminase dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. urgent situation is at least 30 minutes for 500 ml, at long i / v drip infusion because of possible anaphylactoid reaction the first 10 - 20 ml need to type slowly, cautiously hold infusion to patients unwind the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Indications for Single Energy X-ray Absorptiometer drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, Fetal Heart Rate tetraethyl lead, unwind salts barium (Antidote) unwind . normovolemic hemodilution, therapeutic hemodilution. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) in / w test performed for unwind h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the patient: after a slow first 5 Crapo. unwind group: V05AA07 - blood substitutes and plasma protein fraction. polyethylene. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent Intermittent Positive Pressure Ventilation when dealing drug injected drops to 500 ml in case of a significant reduction in moving to SC jet injector; children designate a rate unwind 10 - 15 ml / kg for unwind of burn shock in the first period of adults injected with 2 - 3 liters, and the next day - to 1 500 ml; children unwind the first unwind imposed on 40 - 50 ml / kg body weight, and the next day - up to 30 ml / kg. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling unwind fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein Fetal Hemoglobin The main pharmaco-therapeutic effects: plazmozaminyuyuchyy district with pronounced hemodynamic effect. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated unwind hemodialysis, pregnancy, 1 st trimester. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 Peroxidase or unwind ml vial. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes.